Arriving in the landscape of excess body fat management, retatrutide represents a distinct method. Unlike many existing medications, retatrutide works as a double agonist, concurrently engaging both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) binding sites. This concurrent activation fosters multiple advantageous effe